Health and Healthcare

Eli Lilly : LLY

All Eli Lilly Articles

670 Articles

Lee Jackson | Nov 24, 2015 at 10:47 AM EST

Merrill Lynch 4 Top Pharmaceutical Dividend Stocks To Own For 2016

Despite the howling from political candidates trying to make the top drug-makers their whipping boy in populist campaign efforts, the…

Chris Lange | Nov 18, 2015 at 9:10 AM EST

Jefferies Reveals Top 5 Pharma Stock Picks for Growth and Dividends

Jefferies has updated the thesis behind its "Top 5 for 2015" pharmaceutical stock picks

Jon C. Ogg | Nov 16, 2015 at 8:15 AM EST

Top Analyst Upgrades and Downgrades: Best Buy, CA, Deere, Eli Lilly, Ferrari, Netflix, Oracle, Salesforce.com and More

Monday's top analyst upgrades, downgrades and initiations include Best Buy, CA, Deere, Eli Lilly, Ferrari, Netflix, Oracle and Salesforce.com.

Lee Jackson | Oct 23, 2015 at 8:35 AM EDT

4 Top Merrill Lynch Dividend-Paying Pharmaceutical Stocks to Buy Now

24/7 Wall St. screened the Merrill Lynch research universe for pharmaceutical stocks paying solid dividends that are rated Buy, and…

Chris Lange | Oct 22, 2015 at 10:45 AM EDT

Eli Lilly Rises on Bottom Line Beat

Eli Lilly reported mixed third-quarter financial results on Thursday before the markets opened.

Chris Lange | Oct 21, 2015 at 2:30 PM EDT

What to Expect From Eli Lilly Earnings

Eli Lilly is scheduled to report its third-quarter earnings before the markets open on Thursday.

Jon C. Ogg | Oct 17, 2015 at 9:15 AM EDT

6 Big Companies That Severely Stung Shareholders This Past Week

While there were many winners, last week brought a lot of truly bad news or bad reactions for some of…

Jon C. Ogg | Oct 12, 2015 at 9:55 AM EDT

Eli Lilly Stumbles on Discontinued Drug Trial

Eli Lilly is suffering after bad news about its evacetrapib for high-risk atherosclerotic cardiovascular disease.

Chris Lange | Oct 9, 2015 at 11:20 AM EDT

Why Cholesterol and Alzheimer’s Could Drive Eli Lilly Shares Much Higher

Credit Suisse sees solid upside in this company Eli Lilly as the result of a strong pipeline, with its Alzheimer's…

Jon C. Ogg | Oct 9, 2015 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: AT&T, BioCryst, Eli Lilly, Facebook, Flextronics, Gap, Tesla and More

Friday's top analyst upgrades, downgrades and initiations include AT&T, BioCryst Pharmaceuticals, Eli Lilly, Facebook, Flextronics, Gap and Tesla Motors.

Lee Jackson | Oct 2, 2015 at 10:25 AM EDT

UBS Makes Big Biotech and Pharmaceutical Additions to Equity Focus List

Wikimedia CommonsIf there was ever a time when investors are thrilled to see the calendar change it could be now.…

Lee Jackson | Oct 2, 2015 at 9:20 AM EDT

4 Top Merrill Lynch US Defensive Stock Ideas for Q4

After the worst quarter in the stock market in four years, a new research report from Merrill Lynch includes the…

Lee Jackson | Sep 30, 2015 at 8:35 AM EDT

Merrill Lynch Makes Changes to US 1 List Amid Market Turmoil

The market volatility has left all investors a touch shaken, but the chatter of a bear market and a collapse…

Lee Jackson | Sep 24, 2015 at 9:45 AM EDT

Merrill Lynch Has 4 Pharma Stocks to Buy Against Political Chatter

One positive from the hammering the pharmaceutical stocks have taken is the Merrill Lynch analysts say investors have been given…

Chris Lange | Sep 18, 2015 at 11:45 AM EDT

Why Merrill Lynch Sees More Upside in Eli Lilly

Merrill Lynch reiterated a Buy rating and price objective on Eli Lilly after positive data on its Jardiance.

1 … 31 32 33 34 35 … 45

Eli Lilly : LLY

All Eli Lilly Articles

Merrill Lynch 4 Top Pharmaceutical Dividend Stocks To Own For 2016

Jefferies Reveals Top 5 Pharma Stock Picks for Growth and Dividends

Top Analyst Upgrades and Downgrades: Best Buy, CA, Deere, Eli Lilly, Ferrari, Netflix, Oracle, Salesforce.com and More

4 Top Merrill Lynch Dividend-Paying Pharmaceutical Stocks to Buy Now

Eli Lilly Rises on Bottom Line Beat

What to Expect From Eli Lilly Earnings

6 Big Companies That Severely Stung Shareholders This Past Week

Eli Lilly Stumbles on Discontinued Drug Trial

Why Cholesterol and Alzheimer’s Could Drive Eli Lilly Shares Much Higher

Top Analyst Upgrades and Downgrades: AT&T, BioCryst, Eli Lilly, Facebook, Flextronics, Gap, Tesla and More

UBS Makes Big Biotech and Pharmaceutical Additions to Equity Focus List

4 Top Merrill Lynch US Defensive Stock Ideas for Q4

Merrill Lynch Makes Changes to US 1 List Amid Market Turmoil

Merrill Lynch Has 4 Pharma Stocks to Buy Against Political Chatter

Why Merrill Lynch Sees More Upside in Eli Lilly

If Social Security Cuts Benefits, Here’s Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

AI Architect Earning $1.1M/Year Almost Took on $550K in Debt to Dodge Taxes: ‘I Have No Idea What That Business Is’

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

If Social Security Cuts Benefits, Here’s Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

Eli Lilly : LLY

All Eli Lilly Articles

Merrill Lynch 4 Top Pharmaceutical Dividend Stocks To Own For 2016

Jefferies Reveals Top 5 Pharma Stock Picks for Growth and Dividends

Top Analyst Upgrades and Downgrades: Best Buy, CA, Deere, Eli Lilly, Ferrari, Netflix, Oracle, Salesforce.com and More

4 Top Merrill Lynch Dividend-Paying Pharmaceutical Stocks to Buy Now

Eli Lilly Rises on Bottom Line Beat

What to Expect From Eli Lilly Earnings

6 Big Companies That Severely Stung Shareholders This Past Week

Eli Lilly Stumbles on Discontinued Drug Trial

Why Cholesterol and Alzheimer’s Could Drive Eli Lilly Shares Much Higher

Top Analyst Upgrades and Downgrades: AT&T, BioCryst, Eli Lilly, Facebook, Flextronics, Gap, Tesla and More

UBS Makes Big Biotech and Pharmaceutical Additions to Equity Focus List

4 Top Merrill Lynch US Defensive Stock Ideas for Q4

Merrill Lynch Makes Changes to US 1 List Amid Market Turmoil

Merrill Lynch Has 4 Pharma Stocks to Buy Against Political Chatter

Why Merrill Lynch Sees More Upside in Eli Lilly

If Social Security Cuts Benefits, Here’s Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

AI Architect Earning $1.1M/Year Almost Took on $550K in Debt to Dodge Taxes: ‘I Have No Idea What That Business Is’

Featured Reads

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account